Exploring the Impact of Botulinum Toxin Type A (BoNTA) on Mood During Perimenopause: Emerging Insights

Research output: Contribution to ConferencePosterpeer-review

Abstract

This qualitative study explores the lived experiences of perimenopausal women who have received Botulinum Toxin Type A (BoNTA) treatment, focusing on its perceived impact on mood, identity, and emotional well-being. Through semi-structured interviews and an autoethnographic lens, data were analysed using Feminist Relational Discourse Analysis (FRDA) and I-poems to capture subjective experiences.
Original languageEnglish
Publication statusPublished - 27 Mar 2025
EventAesthetic & Anti-Aging Medicine World Congress - Monaco , Monaco
Duration: 27 Mar 202529 Mar 2025
https://www.amwc-conference.com/en/home.html

Conference

ConferenceAesthetic & Anti-Aging Medicine World Congress
Abbreviated titleAMWC
Country/TerritoryMonaco
Period27/03/2529/03/25
Internet address

Fingerprint

Dive into the research topics of 'Exploring the Impact of Botulinum Toxin Type A (BoNTA) on Mood During Perimenopause: Emerging Insights'. Together they form a unique fingerprint.

Cite this